Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEA 2180 BR in Japanese Healthy Male Volunteers
NCT02254109Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2008
- Primary completion
- Oct 2008
01
Overview
Phase 1, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and asthma comparing BEA 2180 BR - rising dose with Placebo (2 arms). Primary endpoints: Number of subjects with abnormal findings in physical examination, Number of subjects with clinically significant changes in vital signs and 4 more. Started Apr 2008; status: completed.
02
Drugs
bea 2180
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT02254109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254109.